Company Filing History:
Years Active: 2016
Title: Adam Skepner: Innovator in Hepatic Lipoprotein Metabolism
Introduction
Adam Skepner is a notable inventor based in Woburn, MA (US). He has made significant contributions to the field of hepatic cholesterol metabolism through his innovative research and patent work. His dedication to advancing medical science is evident in his patented inventions.
Latest Patents
Adam Skepner holds a patent for "Modulators of hepatic lipoprotein metabolism." This invention relates to compounds that are useful for modulating hepatic cholesterol metabolism in an animal. The patent includes methods of making and using these compounds. Furthermore, it provides methods for treating, preventing, and alleviating cholesterol-related disorders, cardiovascular diseases, and liver diseases in animals, including humans. The administration of these compounds, or their pharmaceutically acceptable salts or solvates, is central to the invention.
Career Highlights
Adam Skepner is associated with The Broad Institute, Inc., where he continues to engage in groundbreaking research. His work focuses on the intersection of biochemistry and medicine, aiming to improve health outcomes through innovative solutions.
Collaborations
Some of his notable coworkers include Marek Maria Nagiec and Jose R Perez. Their collaborative efforts contribute to the advancement of research in the field of hepatic metabolism.
Conclusion
Adam Skepner's contributions to the field of hepatic lipoprotein metabolism through his patent and research at The Broad Institute, Inc. highlight his role as an influential inventor. His work has the potential to impact the treatment of various cholesterol-related disorders significantly.